Investing.com - Apollo Medical (NASDAQ: AMEH) reported third quarter EPS of $0.47, $0.14 better than the analyst estimate of $0.33. Revenue for the quarter came in at $348.2M versus the consensus estimate of $350.1M.
Guidance
Apollo Medical sees FY 2023 EPS of $1.10-$1.20 versus the analyst consensus of $1.28.
Apollo Medical sees FY 2023 revenue of $1.34B-$1.39B versus the analyst consensus of $1.39B.
Apollo Medical's stock price closed at $29.39. It is down -24.62% in the last 3 months and down -20.93% in the last 12 months.
Apollo Medical saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Apollo Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Apollo Medical's Financial Health score is "great performance".
Check out Apollo Medical's recent earnings performance, and Apollo Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar